Phenotypic and physiologic variability in nasal epithelium cultured from smokers and non-smokers exposed to secondhand tobacco smoke.
The emergence of air-liquid interface (ALI) culturing of mammalian airway epithelium is a recent innovation for experimental modeling of airway epithelial development, function, and pathogenic mechanisms associated with infectious agent and irritant exposure. This construct provides an experimental platform for in vitro propagation, manipulation, and testing of airway epithelium in a structural and physiologic state that emulates in vivo organization. In this study, we have cultured nasal epithelial biopsies from human subjects with variable histories of tobacco smoke exposure and assessed ciliary beat frequency (CBF) after an extended interval in vitro relative to CBF determined on biopsies from the same subjects immediately upon acquisition. We observed elevated CBF in nasal epithelial biopsies as well as persistence of accelerated CBF in ALI cultures deriving from biopsies of smokers and non-smokers exposed to environmental tobacco smoke compared to CBF in cultures from biopsies of well-documented non-smokers. Moreover, cultures deriving from smokers exhibited reduced ciliation as the cultures matured. These studies document that nasal epithelium cultured in the ALI system retains physiologic and phenotypic characteristics of the epithelial layer in vivo even through rounds of proliferative expansion. These observations suggest that stable epigenetic factors affecting regulation of ciliary function and phenotype commitment may be operative.
Carson
Johnny L
JL
Center for Environmental Medicine, Asthma, and Lung Biology, The University of North Carolina at Chapel Hill, CB #7310, 104 Mason Farm Road, Chapel Hill, NC 27599-7310, USA. jcarson@med.unc.edu
Lu
Tsui-Shan
TS
Brighton
Luisa
L
Hazucha
Milan
M
Jaspers
Ilona
I
Zhou
Haibo
H
D001681:Biological Assay; D001706:Biopsy; D002478:Cells, Cultured; D002923:Cilia / Q000502:physiology; D003367:Cotinine / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009297:Nasal Mucosa / Q000473:pathology* / Q000502:physiology*; D010641:Phenotype; D012907:Smoking / Q000473:pathology*; D014028:Tobacco Smoke Pollution / Q000032:analysis*
D014028:Tobacco Smoke Pollution; D003367:Cotinine
J Biol Chem. 2004 Aug 13;279(33):35087-100
15180995
J Histochem Cytochem. 1996 May;44(5):463-71
8627003
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):208-13
18635403
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9265-9
2827174
Lab Invest. 1999 Aug;79(8):975-83
10462035
Nature. 1987 Jun 11-17;327(6122):524-6
3495737
J Microsc. 2003 Aug;211(Pt 2):103-11
12887704
Physiol Rev. 2007 Jul;87(3):1047-82
17615396
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1016-21
10712357
Am J Respir Cell Mol Biol. 1993 Oct;9(4):371-7
7691109
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S76-80
11734472
Am J Physiol. 1995 Jun;268(6 Pt 1):L911-7
7541949
Ann Otol Rhinol Laryngol. 1997 Mar;106(3):230-6
9078936
Am J Rhinol. 2006 Jan-Feb;20(1):124-7
16539308
Am J Hypertens. 2008 Jan;21(1):28-34
18091741
Inhal Toxicol. 2009 Aug;21(10):875-81
19555226
Environ Health Perspect. 2009 Feb;117(2):217-22
19270791
Am J Respir Cell Mol Biol. 2010 Sep;43(3):368-75
19880818
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1652-8
15271786
Circ Res. 1999 Dec 3-17;85(12):1192-8
10590247
Biochem Biophys Res Commun. 1993 Feb 26;191(1):83-8
7680560
Nature. 1980 Nov 27;288(5789):373-6
6253831
Am J Respir Cell Mol Biol. 2000 Aug;23(2):175-81
10919983
Pharmacol Rev. 1991 Jun;43(2):109-42
1852778
Free Radic Biol Med. 2007 Jun 15;42(12):1826-37
17512462
J Immunol. 2005 Sep 15;175(6):3846-61
16148131
Am J Physiol. 1995 Jun;268(6 Pt 1):C1342-7
7611351